脑卒中患者的遗传变异性:CYP2C19多态性解开了
Peiyi Peng1, Yingxiu Xiao2, Xuehong Peng3
1Shantou University Medical College, Shantou, Guangdong, China.
BMC medical genomics
|April 26, 2024
概括
汉族中文中风患者中常见的CYP2C19基因变异,但与中风类型,年龄或性别无关. 基因检测可以指导个性化中风治疗.
科学领域:
- 药物基因组学 药物基因组学
- 神经学 神经学
- 遗传学 是一个遗传学.
背景情况:
- CYP2C19基因多态性影响药物代谢,影响治疗疗效.
- 卒中患者经常接受抗血小板药物,如克洛皮多格雷尔,这是CYP2C19.19的基质.
- 了解CYP2C19分布对于优化特定人群中风管理至关重要.
研究的目的:
- 研究汉族中华人中风患者中CYP2C19基因多态的分布特征.
- 分析CYP2C19基因型与患者人口统计或中风类型之间的关系.
- 为了确定这个队列中皮多格雷尔耐药性的潜在风险因素.
主要方法:
- 用PCR和DNA微阵列芯片技术对549名汉族中风患者进行基因定型.
- 对CYP2C19基因型,等位基因频率和代谢类型的分析.
- 统计评估与性别,年龄,心脏病发作类型和克洛皮多格雷尔耐药性的相关性.
主要成果:
- 确定了6种CYP2C19基因型,其中*1/*2是最常见的 (42.44%).
- 在CYP2C19分布与患者的性别,年龄或中风发作类型 (P > 0.05) 之间没有发现显著的关联.
- 这项研究没有确定克洛皮多格雷尔耐药性的独立风险因素.
结论:
- 在汉族中华人的中风患者中,CYP2C19的基因型,等位基因频率和代谢类型与性别,年龄或心脏病发作类型无关.
- 像高血压和脂质失调等常见的并发症在统计学上与CYP2C19基因型无关.
- 建议使用CYP2C19基因定型来指导中风患者个性化药物治疗策略.
相关概念视频
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
131
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
131
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Human Genetics
564
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
564
Nonlinear Pharmacokinetics: Role of Transporters
48
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
48


